产品名称 Ispinesib - SB 715992
产品货号 Axon 2446 CAS [336113-53-2] MF C30H33ClN4O2MW 517.06 Purity: 99% Optical purity: Optically pure Soluble in DMSO and Ethanol Description The first potent, highly specific small-molecule inhibitor of the human kinesin spindle protein (KSP or KIF11 or Eg5), that induces mitosis-phase (M-phase) arrest followed by apoptosis in either the M-phase (via mitotic catastrophe) or G1-phase of the cell-cycle. Ispinesib alters the ability of KSP to bind to microtubules and inhibits its movement by preventing the release of ADP without preventing the release of the KSP−ADP complex from the microtubule References Certificates Categories Extra info J.P. Holland et al. Fluorinated quinazolinones as potential radiotracers for imaging kinesin spindle protein expression. Bioorg Med Chem. 2013 Jan 15;21(2):496-507.   L. Lad et al. Mechanism of inhibition of human KSP by ispinesib. Biochemistry. 2008 Mar 18;47(11):3576-85.   L. Luo et al. ATP-competitive inhibitors of the mitotic kinesin KSP that function via an allosteric mechanism. Nat Chem Biol. 2007 Nov;3(11):722-6. Certificate of Analysis Material Safety Data Sheet Apoptosis Cell Cycle Regulation Cell Signaling & Oncology EC 3.6.4.4 KSP First potent, highly specific small-molecule inhibitor of human KSP Chemical name (R)-N-(3-aminopropyl)-N-(1-(3-benzyl-7-chloro-4-oxo-3,4-dihydroquinazolin-2-yl)-2-methylpropyl)-4-methylbenzamide Parent CAS No. [336113-53-2] Order Size Unit Price Stock 5 mg €120.00 In Stock
产品价格 现货询价,电话:010-67529703
产品规格
产品品牌 axonmedchem
产品概述
产品详情

Ispinesib - SB 715992

Based on 16 reference(s) in Google Scholar 9 10 16

Axon 2446

CAS [336113-53-2]

MF C30H33ClN4O2
MW 517.06

  • Purity: 99%
  • Optical purity: Optically pure
  • Soluble in DMSO and Ethanol

Ispinesib

Description

The first potent, highly specific small-molecule inhibitor of the human kinesin spindle protein (KSP or KIF11 or Eg5), that induces mitosis-phase (M-phase) arrest followed by apoptosis in either the M-phase (via mitotic catastrophe) or G1-phase of the cell-cycle. Ispinesib alters the ability of KSP to bind to microtubules and inhibits its movement by preventing the release of ADP without preventing the release of the KSP−ADP complex from the microtubule
产品资料